Erlejman Alejandra G, De Leo Sonia A, Mazaira Gisela I, Molinari Alejandro M, Camisay María Fernanda, Fontana Vanina, Cox Marc B, Piwien-Pilipuk Graciela, Galigniana Mario D
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and Instituto de Química Biológica de Ciencias Exactas y Naturales (IQUIBICEN)/Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, C1428ADN Argentina.
Border Biomedical Research Center and Department of Biological Sciences, University of Texas, El Paso, Texas 79968.
J Biol Chem. 2014 Sep 19;289(38):26263-26276. doi: 10.1074/jbc.M114.582882. Epub 2014 Aug 7.
Hsp90 binding immunophilins FKBP51 and FKBP52 modulate steroid receptor trafficking and hormone-dependent biological responses. With the purpose to expand this model to other nuclear factors that are also subject to nuclear-cytoplasmic shuttling, we analyzed whether these immunophilins modulate NF-κB signaling. It is demonstrated that FKBP51 impairs both the nuclear translocation rate of NF-κB and its transcriptional activity. The inhibitory action of FKBP51 requires neither the peptidylprolyl-isomerase activity of the immunophilin nor its association with Hsp90. The TPR domain of FKBP51 is essential. On the other hand, FKBP52 favors the nuclear retention time of RelA, its association to a DNA consensus binding sequence, and NF-κB transcriptional activity, the latter effect being strongly dependent on the peptidylprolyl-isomerase activity and also on the TPR domain of FKBP52, but its interaction with Hsp90 is not required. In unstimulated cells, FKBP51 forms endogenous complexes with cytoplasmic RelA. Upon cell stimulation with phorbol ester, the NF-κB soluble complex exchanges FKBP51 for FKBP52, and the NF-κB biological effect is triggered. Importantly, FKBP52 is functionally recruited to the promoter region of NF-κB target genes, whereas FKBP51 is released. Competition assays demonstrated that both immunophilins antagonize one another, and binding assays with purified proteins suggest that the association of RelA and immunophilins could be direct. These observations suggest that the biological action of NF-κB in different cell types could be positively regulated by a high FKBP52/FKBP51 expression ratio by favoring NF-κB nuclear retention, recruitment to the promoter regions of target genes, and transcriptional activity.
热休克蛋白90结合免疫亲和素FKBP51和FKBP52调节类固醇受体转运和激素依赖性生物学反应。为了将该模型扩展到其他也经历核质穿梭的核因子,我们分析了这些免疫亲和素是否调节核因子κB(NF-κB)信号传导。结果表明,FKBP51损害NF-κB的核转位速率及其转录活性。FKBP51的抑制作用既不需要免疫亲和素的肽基脯氨酰异构酶活性,也不需要其与热休克蛋白90的结合。FKBP51的四肽重复(TPR)结构域至关重要。另一方面,FKBP52有利于RelA的核滞留时间、其与DNA共有结合序列的结合以及NF-κB转录活性,后一种效应强烈依赖于肽基脯氨酰异构酶活性以及FKBP52的TPR结构域,但不需要其与热休克蛋白90的相互作用。在未受刺激的细胞中,FKBP51与细胞质中的RelA形成内源性复合物。在用佛波酯刺激细胞后,NF-κB可溶性复合物将FKBP51换成FKBP52,并触发NF-κB生物学效应。重要的是,FKBP52在功能上被募集到NF-κB靶基因的启动子区域,而FKBP51被释放。竞争试验表明,这两种免疫亲和素相互拮抗,并且用纯化蛋白进行的结合试验表明RelA与免疫亲和素的结合可能是直接的。这些观察结果表明,通过有利于NF-κB的核滞留、募集到靶基因的启动子区域以及转录活性,高FKBP52/FKBP51表达比可能对不同细胞类型中NF-κB的生物学作用起到正向调节作用。